(Q33722396)

28 July 2017

title

Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice (English)

1 reference

28 July 2017

0 references

Masafumi Ono

1

1 reference

28 July 2017

Mitsunari Ogasawara

2

1 reference

28 July 2017

Akira Hirose

3

1 reference

28 July 2017

Sachiko Mogami

4

1 reference

28 July 2017

Nobuhiro Ootake

5

1 reference

28 July 2017

Kosuke Aritake

6

1 reference

28 July 2017

Takuma Higuchi

7

1 reference

28 July 2017

Nobuto Okamoto

8

1 reference

28 July 2017

Shuji Sakamoto

9

1 reference

28 July 2017

Masahiro Yamamoto

10

1 reference

28 July 2017

Yoshihiro Urade

11

1 reference

28 July 2017

Toshiji Saibara

12

1 reference

28 July 2017

Jude A Oben

13

1 reference

28 July 2017

publication date

26 June 2013

1 reference

Journal of Gastroenterology

28 July 2017

published in

1 reference

28 July 2017

volume

49

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

1065-1073

1 reference

Creative Commons Attribution-NonCommercial 2.5 Generic

28 July 2017

copyright license

start time

26 June 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Adipocytokines and liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

The Kampo medicines Orengedokuto, Bofutsushosan and Boiogito have different activities to regulate gene expressions in differentiated rat white adipocytes: comprehensive analysis of genetic profiles

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Molecular mechanism of moderate insulin resistance in adiponectin-knockout mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Effects of colestimide and/or Bofu-tsusho-san on plasma and liver lipids in mice fed a high-fat diet

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

The crucial role of particle surface reactivity in respirable quartz-induced reactive oxygen/nitrogen species formation and APE/Ref-1 induction in rat lung

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Molecular mediators of hepatic steatosis and liver injury

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Role of Akt/protein kinase B in metabolism.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.

21 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

Preventive effects of Bofutsushosan on obesity and various metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

Effects of three Chinese herbal medicines on plasma and liver lipids in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0852-8

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048468

PPARalpha in the pathogenesis of fatty liver disease

30 October 2018

1 reference

12 December 2020

Non-alcoholic steatohepatitis: another disease of affluence

1 reference

12 December 2020

TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c)

1 reference

12 December 2020

Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis

1 reference

12 December 2020

10.1007/S00535-013-0852-8

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference